First Time Loading...

Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211

Watchlist Manager
Tibet Rhodiola Pharmaceutical Holding Co Logo
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Watchlist
Price: 35.97 CNY -1.13% Market Closed
Updated: Jun 10, 2024

Tibet Rhodiola Pharmaceutical Holding Co
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tibet Rhodiola Pharmaceutical Holding Co
Other Liabilities Peer Comparison

Comparables:
1099
601607
600998
C
600511
000963

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Tibet Rhodiola Pharmaceutical Holding Co
SSE:600211
Other Liabilities
¥25.9m
CAGR 3-Years
34%
CAGR 5-Years
14%
CAGR 10-Years
0%
Sinopharm Group Co Ltd
HKEX:1099
Other Liabilities
¥3.9B
CAGR 3-Years
-1%
CAGR 5-Years
20%
CAGR 10-Years
12%
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Other Liabilities
¥922.5m
CAGR 3-Years
-31%
CAGR 5-Years
-6%
CAGR 10-Years
-2%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Other Liabilities
¥360.7m
CAGR 3-Years
4%
CAGR 5-Years
-1%
CAGR 10-Years
23%
C
China National Medicines Corp Ltd
SSE:600511
Other Liabilities
¥793.6m
CAGR 3-Years
43%
CAGR 5-Years
32%
CAGR 10-Years
17%
Huadong Medicine Co Ltd
SZSE:000963
Other Liabilities
¥362.7m
CAGR 3-Years
33%
CAGR 5-Years
2%
CAGR 10-Years
33%

See Also

What is Tibet Rhodiola Pharmaceutical Holding Co's Other Liabilities?
Other Liabilities
25.9m CNY

Based on the financial report for Mar 31, 2024, Tibet Rhodiola Pharmaceutical Holding Co's Other Liabilities amounts to 25.9m CNY.

What is Tibet Rhodiola Pharmaceutical Holding Co's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
0%

Over the last year, the Other Liabilities growth was -6%. The average annual Other Liabilities growth rates for Tibet Rhodiola Pharmaceutical Holding Co have been 34% over the past three years , 14% over the past five years .